HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A Case of Non-Resectable Pancreatic Cancer with Multiple Hepatic Metastases Treated with FOLFIRINOX Therapy and Conversion Surgery].

Abstract
A 50-year-old woman was diagnosed as having pancreatic head cancer with multiple hepatic metastases. FOLFIRINOX therapy was initiated. After completing 18 courses of therapy, partial remission(PR)was achieved based on images, and surgery was then planed. The subtotal stomach-preserving pancreaticoduodenectomy and hepatic S7 partial resection were performed. Macroscopically, complete resection was achieved. Regarding pathological findings of the primary lesion and hepatic metastatic lesions, fibrous formation and hyalinizing condition induced by chemotherapy were noted; moreover, complete disappearance of cancer cells was detected. However, metastasis of poorly differentiated adenocarcinoma was detected in 12b lymph node tissue. One month after the surgery, postoperative adjunctive chemotherapy with S-1 was initiated. However, new hepatic metastasis was detected 3 months after the surgery. Although recurrence treatment was initiated, the disease progressed, and the patient died 11 months after the surgery.
AuthorsTakanobu Akaishi, Keinosuke Ishido, Norihisa Kimura, Hayato Nagase, Tadashi Odagiri, Hiroaki Fujita, Yu Chen, Kensuke Saito, Takenori Takahata, Atsushi Sato, Kenichi Hakamada
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 46 Issue 13 Pg. 2551-2553 (Dec 2019) ISSN: 0385-0684 [Print] Japan
PMID32156995 (Publication Type: Case Reports, Journal Article)
Topics
  • Antineoplastic Combined Chemotherapy Protocols
  • Female
  • Humans
  • Liver Neoplasms (drug therapy, secondary)
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Pancreatic Neoplasms (drug therapy, surgery)
  • Pancreaticoduodenectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: